Thermo Fisher subsidizes more sequencers for global coronavirus research

By The Science Advisory Board staff writers

January 14, 2021 -- Thermo Fisher Scientific is expanding a global SARS-CoV-2 program that provides its next-generation sequencers at subsidized prices to help analyze new strains of the virus and trace community transmission.

The company said that it set up the SARS-CoV-2 GlobalAccess Sequencing program in May with the goal of accelerating multi-institutional efforts at mapping coronavirus transmission and furthering understanding of disease epidemiology. Nowadays, the B.1.1.7 U.K. variant and other new strains of the virus are causing alarm.

The expansion involves the provision of additional units of the company's Ion Torrent Genexus System and Ion GeneStudio S5 sequencers, Thermo Fisher said.

Thermo Fisher launches managed equipment plan
Thermo Fisher Scientific has launched a new subscription-based program called Managed Equipment Solutions that combines instrument and equipment sales...
New evidence shows SARS-CoV-2 mutations are not more transmissible
In direct contrast to previous research, researchers found that SARS-CoV-2 mutations are not tied to increased transmissibility in humans. The findings,...
Are SARS-CoV-2 mutations more contagious than the original virus?
The SARS-CoV-2 virus has accumulated genetic mutations that may make it more contagious and more easily spread in metropolitan communities, according...
Will mutation of the SARS-CoV-2 virus affect vaccine effectiveness?
What impact will mutation of the SARS-CoV-2 virus have on the effectiveness of COVID-19 vaccines that are in development? In a new study published in...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter